No Data
No Data
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat
Investors in West Pharmaceutical Services (NYSE:WST) Have Seen Decent Returns of 64% Over the Past Five Years
UBS Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Maintains Target Price $285
Express News | FOMC Projects Lower GDP and Uncertainty, No Rate Change
Unlock the Full List